Tinea Pedis Treatment Market, By Drug Class (Allylamines and Benzylamines (e.g., terbinafine, naftifine, etc.), Azoles (e.g., clotrimazole, miconazole, etc.), Hydroxypyridones (e.g., ciclopirox), Morpholines (e.g., amorolfine), and Others (e.g., tolnaftate, undecylenic acid)), By Route of Administration (Topical and Oral), By Formulation (Creams and Ointments, Sprays, Powders, Gels, Tablets, Capsules, and Solution), By Prescription Type (Over-the-counter (OTC) and Prescription (Rx)), By Age Group (Pediatric, Adult, and Geriatric), By Infection Type (Interdigital, Moccasin (chronic hyperkeratotic), Vesiculobullous, and Ulcerative), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By End User (Hospitals, Dermatology Clinics, Homecare Settings, and Outpatient/Primary care), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Growth Trends and Forecasts (2025-2032)